Targeting B7-H3—A Novel Strategy for the Design of Anticancer Agents for Extracranial Pediatric Solid Tumors Treatment

Recent scientific data recognize the B7-H3 checkpoint molecule as a potential target for immunotherapy of pediatric solid tumors (PSTs). B7-H3 is highly expressed in extracranial PSTs such as neuroblastoma, rhabdomyosarcoma, nephroblastoma, osteosarcoma, and Ewing sarcoma, whereas its expression is...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasic, Petar, Jeremic, Marija, Jeremic, Rada, Dusanovic Pjevic, Marija, Rasic, Milica, Djuricic, Slavisa M., Milickovic, Maja, Vukadin, Miroslav, Mijovic, Tanja, Savic, Djordje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145344/
https://www.ncbi.nlm.nih.gov/pubmed/37110590
http://dx.doi.org/10.3390/molecules28083356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145344/
https://www.ncbi.nlm.nih.gov/pubmed/37110590
http://dx.doi.org/10.3390/molecules28083356

Ejemplares similares